TrialBritish journal of cancer2018

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006.

Omid Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.